胺苯吖啶治疗急性白血病患者的静脉保护  

Venous protection of acute leukemia treatment with amsacrine

作　　者：马新娟 项英妹 蒋红 李燕 刘青英 张慧敏 孙广萍 柯欣 

机构地区：[1]中国医学科学院血液学研究所血液病医院

出　　处：《中华护理杂志》1996年第9期506-507,共2页Chinese Journal of Nursing

摘　　要：胺苯吖啶（ＡＭＳＡ）是一种高效治疗急性白血病的药物，但是静脉滴注时可引起严重的静脉炎，影响治疗。我们对４４例患者进行了７１疗程的ＡＭＳＡ治疗，采用在ＡＭＳＡ静脉滴注后用大剂量５％葡萄糖快速静脉滴注，稀释高浓度ＡＭＳＡ，使静脉炎的发生明显减少，并采取早期综合护理，使静脉炎迅速痊愈。Amsacrine(AMSA) was a high effective medicine of acute leukemia treatment.But it could lead to severe phlebitis with venous drip.44 patients were treated 71 courses with AMSA.After we used fasting venous drip and diluting high concentration AMSA,occurence of phlebitis remarkably decreased and patients of phlebitis could be cured with early comprehensive nursing.

关 键 词：胺苯吖啶 静脉炎 护理学 白血病 

分 类 号：R733.710.5[医药卫生—肿瘤] R473.73[医药卫生—临床医学]